matic disulphide NSC20625 was a very potent virucidal agent, whereas the other two compounds exhibited moderate or negligible virus-inactivating properties.
The Arenaviridae is a family of enveloped viruses containing two genome single-stranded RNA segments, large (L) and small (S), both with an ambisense coding arrangement. Only five proteins are expressed from the two genome fragments: the S RNA encodes the major structural proteins, nucleocapsid protein (NP) and two envelope glycoproteins (external GP1 and transmembrane GP2), whereas the L RNA encodes the RNA polymerase protein L and an 11-kDa protein called Z or p11 with unknown function. The Z protein was the last to be described when the sequences of the L segments of lymphocytic choriomeningitis virus (LCMV) (Salvato & Shimomaye, 1989) , Tacaribe virus (TACV) (Iapalucci et al., 1989) and Lassa virus (Djavani et al., 1997) were completed. The Z protein sequences in members of the Arenaviridae family maintain a Cys 3 HisCys 4 RING-finger motif, a type of Zn-binding polypeptide sequence that coordinates two zinc ions (Saurin et al., 1996) . It has been shown that the LCMV Z protein effectively binds Zn in vitro (Salvato & Shimomaye, 1989) .
Several arenaviruses are human pathogens capable of causing severe haemorrhagic fevers. In particular, Junin virus ( JUNV) is the agent of Argentine haemorrhagic fever (AHF), an endemo-epidemic disease affecting the population of the most fertile zone of Argentina (Weissenbacher et al., 1987) . Although several compounds were found to be selective inhibitors of the in vitro replication of JUNV (Andrei & De Clercq, 1990; Candurra et al., 1996 Cordo et al., 1999) , no reliable drug therapy is presently available for the treatment of AHF. Ribavirin is the only compound that has shown partial efficacy against JUNV infections but with a high level of undesirable secondary reactions (McKee et al., 1988; Enria & Maiztegui, 1994) . Thus, the treatment for AHF consists of the early administration of standardized doses of convalescent plasma, however, this therapy is not efficient when it is initiated after 8 days of illness and a late neurological syndrome is observed in 10% of patients treated (Enria & Maiztegui, 1994) .
Zn-binding proteins with cysteine-rich Zn-finger motifs seem to represent a potential novel strategy for antiviral chemotherapy. Recent studies have identified a series of chemotypes that selectively target the retroviral Zn-finger motifs of human immunodeficiency virus type 1 
Introduction
(HIV-1) nucleocapsid protein p7 (NCp7), causing Zn ejection from the protein, loss of its native structure and inhibition of virus replication (Rice et al., 1996; Tummino et al., 1997; Witvrouw et al., 1997) . Since the Zn-binding domain in the 11 kDa Z protein of several arenaviruses is highly conserved, this protein is an attractive target for antiviral action. In the present study we evaluated selected retroviral Zn-finger agents for their capacity to act as arenavirus inhibitors.
Fifteen compounds with known activity toward HIV-1 NCp7 Zn-fingers and representative of diverse chemical structures were provided by William Rice (National Cancer Institute-Frederick Cancer Research and Development Center, SAIC Frederick, Md., USA). Stock solutions at a CC Garcia et al.
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©2000 International Medical Press concentration of 100 mM were prepared in DMSO. Ribavirin (Sigma-Aldrich) was used as a reference substance. Antiviral activity was evaluated by a virus yield inhibition assay in Vero cell monolayers grown in 24-well microplates and infected with JUNV, strain IV4454, in the presence of different concentrations of the compounds. After 48 h of infection, supernatant cultures were harvested and extracellular virus yields were determined by plaque formation. The effective concentration 50% (EC 50 ) and the effective concentration 90% (EC 90 ) were calculated as the concentrations required to reduce virus yield by 50 and 90%, respectively, in the compound-treated cultures compared with the untreated ones. Cytotoxicity was measured by the dye uptake method using 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide (MTT, Sigma-Aldrich, USA) in Vero cells grown in 96 well-plates, using conditions equivalent to those used in antiviral assays (48 h of incubation at 37°C). Results were expressed as the cytotoxic concentration 50% (CC 50 ) compound concentration required to reduce the MTT signal by 50% compared to controls.
The compounds tested were grouped into two categories according to their chemical structure (Tables 1 and 2 ). The first category of compounds consisted of eight diverse disulphide-based compounds. All these compounds were moderate or highly active against JUNV, with EC 50 values ranging from 4.6-100 µM (Table 1) . However, the thiuram disulphide 5-7 was too toxic to be considered a valuable Structure antiviral. Among the aromatic disulphides, two compounds (NSC4493 and NSC20625) were both selective inhibitors of JUNV with selectivity indices of around 10, but NSC20625 exhibited a strong efficacy because its EC 50 was fourfold lower than the corresponding NSC4493. Finally, the two cis and trans isomers of 1,2-dithiane-4,5-diol, 1,1-dioxide (NSC624151 and NSC624152, respectively) were demonstrated to be active against JUNV, although the cisdiol 624151 exerted a slightly superior effectivity with an EC 50 of 17.0 µM and CC 50 >400 µM. The most active inhibitors showed similar or higher efficacy in vitro than ribavirin (Table 1) . From the seven azoic and hydrazide derivatives tested, three were totally inactive, two demonstrated moderate anti-JUNV activity, whereas two compounds, 3-7, 2-(2-nitroso-1-naphthylazo)benzoic acid and 2-71, 2-(carbamoylthio)-acetic acid 2-phenyl hydrazide, were truly active toward JUNV with EC 50 values of 6.5 and 8.9 µM, respectively ( Table 2 ). In addition, the CC 50 of these two compounds greatly exceeded the effective antiviral doses, thus resulting in selectivity indices of 30.0 and 58.0 for 2-71 and 3-7, respectively.
The anti-arenavirus activity of both chemical classes of compounds was comparable to their antiretroviral effect against HIV as previously reported (Rice et al., 1996; 1997a,b) .
The antiviral potency of the active compounds was also evaluated by a plaque reduction assay against JUNV in Vero cells. For example, the concentrations required to reduce the plaque number by 50% for NSC20625, 2-71 and the reference compound ribavirin, were 5.7, 22.0 and 17.9 µM, respectively. These values are of little difference to the EC 50 obtained by virus yield inhibition assay (Tables 1 and 2). Three compounds, NSC20625, 3-7 and 2-71, representatives of different chemical structures and with EC 50 values lower than 10 µM and SI greater than 10, were further examined for their inhibitory action on arenaviruses. These compounds effectively inhibited the replication of several strains of JUNV, including attenuated isolates such as the above mentioned IV4454 and the XJCl3 and Cl67 strains, as well as the highly pathogenic XJ strain (Table 3) . When other species of arenaviruses were tested, the values of EC 50 for TACV, an arenavirus closely related to JUNV as shown by antigenic cross-reactivity and in vivo protection studies (Martinez Peralta et al., 1993) , and for Pichinde virus (PICV) were similar to those obtained for JUNV (Table 3) . In most cases, the disulphide NSC20625 was the most active compound.
As a first approach to characterize the action of these three compounds on arenaviruses, an assay of virucidal activity was performed. To this end, a virus suspension containing 1×10 6 PFU of JUNV was exposed for 1.5 h at 37°C to various concentrations of compounds and samples were then chilled and diluted to determine residual infectivity by plaque formation. The sample dilution effectively reduced the drug concentration to be incubated with the cells by at least 100-fold and was below the effective antiviral concentration EC 50 . The comparison between the antiviral action in infected cells and the inactivating effect on virus particles against two arenaviruses, JUNV and TACV (Figure 1) , has demonstrated different types of behaviour for these three agents. The aromatic disulphide NSC20625 was the most potent virucidal agent, reducing virus titres more than 3 log 10 at concentrations below 5 µM. From the data in Figure 1 , the inactivating concentration 50% (IC 50 ) of NSC20625 was calculated to be 0.7 and 1.3 µM against JUNV and TACV, respectively, whereas the corresponding EC 50 values in virus yield inhibition assays were 9.3 and 3.6 µM, respectively (Table 3 ). The virucidal potency of NSC20625 was more clearly shown when IC 90 was compared to the virus yield EC 90 : for JUNV the IC 90 and the EC 90 were 1.6 and 50.0 µM, respectively, whereas for TACV the IC 90 was 3.1 µM and the EC 90 was 37.6 µM. In contrast, the compound 3-7 only inactivated TACV virion CC Garcia et al. infectivity by 50% at a concentration as high as 40 µM whereas its virucidal activity against JUNV was negligible.
The compound 2-71 demonstrated an intermediate behaviour with the same pattern of curves for antiviral and virucidal activities against both viruses (Figure 1) , and the extrapolated values of IC 50 (31.3 and 21.1 µM for JUNV and TACV, respectively) were similar to the corresponding EC 50 shown in Table 3 . The variable ability to inactivate JUNV and TACV virions, demonstrated by the compounds shown in Figure 1 , independently of their virus yield inhibitory effect, prompted us to evaluate the virucidal activity of all the series of Zn-finger active drugs. Results obtained confirmed the lack of a direct correlation between antiviral effect in infected cells and the virus inactivating action of these compounds. The two dithianes NSC624151 and 624152, the aldrithiol-2 4-16 and even the azodicarbonamide (ADA) A9660, inactive in virus yield inhibition assay (Table 2) , exhibited a very important virucidal activity as NSC20625, with IC 50 and IC 90 values 5-15-fold lower than the corresponding EC 50 and EC 90 doses, whereas the remaining compounds showed the same behaviour in the antiviral test as they did in the virucidal assay (data not shown). The major finding of the present study is the demonstration that many known antiretroviral Zn-finger active compounds with diverse chemical structures have inhibitory activity against arenaviruses. Although the majority of the most active substances were disulphide-based compounds, a wider spectrum of related compounds must be tested to clearly establish direct structure-activity relationships.
The mode of action of Zn-finger active compounds against HIV is the destruction of Zn-finger motifs in the nucleocapsid protein NCp7. At present, the mode of action against arenaviruses is unclear and further research is required to explain the different behaviours of the compounds and elucidate whether compounds interact with Znfinger domains in arenavirus proteins or act through another mechanism. However, the ability of NSC20625 and other compounds to inactivate JUNV and TACV virions was coincidental with the virucidal activity against HIV shown by these agents, which entered the intact HIV particle and caused viral inactivation by cross-linking the NCp7 protein after Zn ejection (Rice et al., 1997a; Tummino et al., 1997) . It is noteworthy that the disulphide compounds that are most active in vitro against arenaviruses have also shown the highest ability to eject Zn from the NCp7 protein of HIV (Rice et al. 1996) . Studies are in progress to test the ability of these inhibitors to eject Zn from a recombinant arenavirus Z protein and consequently, alter its interaction with other viral proteins in virions leading to loss of infectivity.
Zn-finger proteins are essential for normal cellular function. However, it must be noted that the non-cytotoxic effect of these inhibitors was observed for an even more prolonged period of incubation, up to 6 days (data not shown). Furthermore, experimental evidence has shown three antiviral agents that target retroviral nucleocapsid protein Zn-fingers, including the dithiane NSC624151, did not impact the functions of cellular Zn-finger proteins (Huang et al., 1998) . Thus, the anti-arenavirus efficacy of several compounds reported here appears to be indicative of a true selective reactivity and such compounds should be further investigated in vivo against arenaviruses in mouse and guinea pig models.
